Biofrontera Inc. (BFRI)
USD 0.8
(-4.64%)
USD 0.8
(-4.64%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.62 Million USD | 15.38% |
| 2022 | 13.48 Million USD | 18.76% |
| 2021 | 11.35 Million USD | 16.1% |
| 2020 | 9.78 Million USD | -28.97% |
| 2019 | 13.77 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.38 Million USD | -11.58% |
| 2024 Q1 | 3.95 Million USD | -19.83% |
| 2023 Q3 | 4.38 Million USD | 48.11% |
| 2023 FY | 15.56 Million USD | 15.38% |
| 2023 Q4 | 4.93 Million USD | 12.52% |
| 2023 Q2 | 2.96 Million USD | -28.42% |
| 2023 Q1 | 4.13 Million USD | -15.41% |
| 2022 Q2 | 1.9 Million USD | -58.64% |
| 2022 Q1 | 4.6 Million USD | 4.69% |
| 2022 FY | 13.48 Million USD | 18.76% |
| 2022 Q4 | 4.88 Million USD | 133.09% |
| 2022 Q3 | 2.09 Million USD | 10.19% |
| 2021 FY | 11.35 Million USD | 16.1% |
| 2021 Q4 | 4.39 Million USD | 115.02% |
| 2021 Q3 | 2.04 Million USD | -25.59% |
| 2021 Q2 | 2.74 Million USD | 26.42% |
| 2021 Q1 | 2.17 Million USD | -47.61% |
| 2020 Q2 | 1.16 Million USD | -48.12% |
| 2020 FY | 9.78 Million USD | -28.97% |
| 2020 Q4 | 4.14 Million USD | 85.26% |
| 2020 Q3 | 2.23 Million USD | 93.02% |
| 2020 Q1 | 2.23 Million USD | 0.0% |
| 2019 FY | 13.77 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 94.902% |
| Embecta Corp. | 749.9 Million USD | 97.783% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 94.554% |
| Dynavax Technologies Corporation | 182.11 Million USD | 90.87% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 77.244% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 96.609% |
| PainReform Ltd. | -15 Thousand USD | 110946.667% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 44.115% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -99.384% |
| SCYNEXIS, Inc. | 124.51 Million USD | 86.647% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -2901.421% |
| Cosmos Health Inc. | 4.34 Million USD | -282.268% |
| Journey Medical Corporation | 52.52 Million USD | 68.342% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -99.384% |
| Safety Shot Inc | -74.45 Thousand USD | 22431.01% |
| Alpha Teknova, Inc. | 10.29 Million USD | -61.49% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 96.139% |
| Bright Green Corporation | -237.01 Thousand USD | 7115.138% |
| Procaps Group, S.A. | 239.56 Million USD | 93.06% |
| Theratechnologies Inc. | 62.12 Million USD | 73.238% |
| Harrow Health, Inc. | 90.55 Million USD | 81.638% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -250.411% |
| DURECT Corporation | 6.83 Million USD | -143.405% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 96.825% |
| Cronos Group Inc. | 6.99 Million USD | -137.838% |
| OptiNose, Inc. | 62.35 Million USD | 73.335% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 96.231% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 5587.459% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -444.403% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 94.633% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -208.22% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 50.346% |
| Radius Health, Inc. | 307.71 Million USD | 94.597% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -64.985% |
| ProPhase Labs, Inc. | 16.23 Million USD | -2.389% |
| Phibro Animal Health Corporation | 312.48 Million USD | 94.679% |
| Procaps Group S.A. | 239.56 Million USD | 93.06% |
| Alvotech | -69.42 Million USD | 123.951% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -1177.035% |
| Viatris Inc. | 6.43 Billion USD | 99.742% |
| Rockwell Medical, Inc. | 8.7 Million USD | -91.027% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 69.54% |
| SIGA Technologies, Inc. | 122.09 Million USD | 86.382% |
| Tilray Brands, Inc. | 223.35 Million USD | 92.556% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 60.27% |
| Shineco, Inc. | 882.16 Thousand USD | -1784.788% |
| PetIQ, Inc. | 252.74 Million USD | 93.421% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 2330.052% |
| Incannex Healthcare Limited | 12 Thousand USD | -138458.333% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 99.1% |
| Alimera Sciences, Inc. | 61.17 Million USD | 72.818% |
| Silver Spike Investment Corp. | 8.1 Million USD | -105.206% |
| Assertio Holdings, Inc. | 125.04 Million USD | 86.704% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 244219.806% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -296.715% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -153.615% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 789.867% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 38.684% |
| Hempacco Co., Inc. | -1.21 Million USD | 1467.54% |
| Talphera, Inc. | -4.89 Million USD | 439.673% |
| Alvotech | -69.42 Million USD | 123.951% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 92.499% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 97.657% |
| Currenc Group, Inc. | 17.35 Million USD | 4.202% |
| Kamada Ltd. | 52.59 Million USD | 68.385% |
| Indivior PLC | 907 Million USD | 98.167% |
| Evoke Pharma, Inc. | 4.97 Million USD | -233.959% |
| Flora Growth Corp. | 17.73 Million USD | 6.263% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 789.867% |
| Evolus, Inc. | 140.52 Million USD | 88.168% |
| HUTCHMED (China) Limited | 453.55 Million USD | 96.334% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 95.166% |
| Akanda Corp. | 111.44 Thousand USD | -14818.932% |